Legal Opinion

In Re Fenofibrate Patent Litigation

United States Judicial Panel on Multidistrict Litigation

Decided May 23, 2011No. MDL No. 2819Published

1Opinion of the Court

TRANSFER ORDER

JOHN G. HEYBURN II, Chairman.

Before the Panel: * Pursuant to 28 U.S.C. § 1407, plaintiff Lupin Atlantis Holdings S.A. (Lupin) moves for centralized pretrial proceedings of this litigation in the Eastern District of Pennsylvania. Plaintiffs’ motion encompasses six actions pending in four districts, as listed on Schedule A. 1

Mylan defendants 2 do not oppose centralization in the Eastern District of Pennsylvania, and the Ranbaxy defendants 3 do not oppose centralization so long as it does not delay resolution of a motion for summary judgment they intend to file in the Ranbaxy…

2Cases cited1 opinion

  1. In Re: Rosuvastatin Calcium Patent LitigationUnited States Judicial Panel on Multidistrict Litigation · 2008

Showing a preview — retrieve the full document via the Exa API.

Powered by the Exa API